Laboratory News and Research

RSS

COVID-19 vaccination provides higher concentrations of antibodies to babies and pregnant people

Pregnant people who received one of the mRNA COVID-19 vaccines had 10-fold higher antibody concentrations than those who were naturally infected with SARS-CoV-2, a finding that was also observed in their babies, according to a new study by researchers at Children's Hospital of Philadelphia and the University of Pennsylvania.

9 Nov 2022

Researchers discover residual tumor cells responsible for colon cancer relapse

Colon cancer is the third most common cancer in the world, with about 2 million new cases each year. Most patients are diagnosed when the tumor is still located in the colon or rectum.

9 Nov 2022

New tool maps how breast cancer grows in previously unseen detail

New technology can trace which populations of breast cancer cells are responsible for the spread of the disease, and for the first time highlights how the location of cancer cells could be as important as mutations in tumor growth.

9 Nov 2022

Pioneering research identifies a promising treatment approach for myelofibrosis

Pioneering research into the chronic inflammation often seen in certain blood cancers has identified a promising treatment approach for myelofibrosis, a potentially deadly bone marrow cancer.

9 Nov 2022

New program leverages digital solutions to improve patients' blood pressure and cholesterol levels

Heart disease is the leading cause of death in the United States and around the world. Lowering high blood pressure and cholesterol could help to reduce morbidity and mortality, but frequent in-person visits to measure and manage these readouts can be a burden for patients.

9 Nov 2022

Immunological responses against monkeypox virus concerning the 2022 outbreak

A new study aimed to analyze the kinetics of the pox-specific T-cell induction, the inflammatory profile, and the inflammatory profile in human cases of the current monkeypox outbreak.

9 Nov 2022

Does fenofibrate improve clinical outcomes in patients with COVID-19?

Researchers assessed the effect of fenofibrate on acute COVID-19.

9 Nov 2022

The effect of vaccination-induced immunity on viral loads of SARS-CoV-2 Omicron variant

Researchers analyzed nationwide vaccination data and cycle threshold value data from four laboratories in Israel that conduct SARS-CoV-2 qRT-PCR tests to determine the effect of vaccination-induced immunity on the viral loads of the SARS-CoV-2 Omicron variant.

9 Nov 2022

Highly processed and refined foods contribute to rising obesity rates in the Western world

A year-long study of the dietary habits of 9,341 Australians has backed growing evidence that highly processed and refined foods are the leading contributor of rising obesity rates in the Western world.

9 Nov 2022

Outcomes from an Australian COVID-19 virtual ward during Omicron wave

In a recent study posted to the medRxiv* preprint server, researchers in Australia characterized hospitalization volumes, patient epidemiological and clinical outcome data of patients admitted to virtual wards during the predominance of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of concern (VOC) BA.1 sub-VOC and the Omicron BA.2 sub-VOC.

8 Nov 2022

New insight into how childhood traumas affect health outcomes

The social environments we grow up in are critical when determining our wellbeing and health later in life. Most Americans (67%) report experiencing at least one traumatic event in childhood, and a new study shows that these experiences have significant impacts on our health risks as adults.

8 Nov 2022

Terasaki Innovation Summit to focus on improving technological, entrepreneurial translation of personalized medicines

The Terasaki Institute for Biomedical Innovation (TIBI) will be hosting the Terasaki Innovation Summit on March 8-10, 2023, at the UCLA Meyer & Renee Luskin Center in Los Angeles.

8 Nov 2022

MGI Partners with ALACRiS Theranostics to Open New Customer Experience Center in Germany

MGI, a company committed to building core tools and technology to lead life science, today announced the launch of its new Customer Experience Center (CEC) in Berlin, Germany.

From MGI 8 Nov 2022

Low-protein highly processed foods lead to higher energy intake

8 Nov 2022

Study identifies a potential pharmacological target for treating COVID-19-associated heart failure

Researchers at the University of Maryland School of Medicine's (UMSOM) Center for Precision Disease Modeling identified how a specific protein in SARS-CoV-2, the virus responsible for COVID-19, damages heart tissue. They then used a drug to reverse the toxic effects of that protein on the heart.

8 Nov 2022

Study: Fenofibrate not a useful strategy for decreasing COVID-19 severity

After showing promise in early laboratory research, the cholesterol-lowering drug fenofibrate had no significant effect on COVID-19 outcomes in a multicenter international randomized clinical trial led by Penn Medicine scientists.

8 Nov 2022

Study uncovers a previously unknown propofol effect in neurons

Propofol is the most commonly used drug to induce general anesthesia. Despite its frequent clinical application, it is poorly understood how propofol causes anesthesia.

7 Nov 2022

Study helps to justify the use of Ayres Sensory Integration as a tool for autistic children

People with autism are often portrayed in popular media as experiencing difficulty processing highly stimulating or overly loud environments.

7 Nov 2022

New analysis finds significant disparities in the treatment of familial hypercholesterolemia

The Family Heart Foundation, a leading research and advocacy organization, shared results from an analysis of its large U.S. Family Heart DatabaseTM showing significant disparities exist in the treatment of familial hypercholesterolemia (FH) among racial groups, and by income and education levels.

7 Nov 2022

EKF to showcase POCT connectivity solutions at MEDICA 2022

EKF Diagnostics, a global diagnostics company, will be introducing its latest product developments and offerings at MEDICA 2022, Düsseldorf, Germany, 14-17 November.

From EKF Diagnostics 7 Nov 2022

Laboratory News and Research

COVID-19 vaccination provides higher concentrations of antibodies to babies and pregnant people

Researchers discover residual tumor cells responsible for colon cancer relapse

New tool maps how breast cancer grows in previously unseen detail

Pioneering research identifies a promising treatment approach for myelofibrosis

New program leverages digital solutions to improve patients' blood pressure and cholesterol levels

Immunological responses against monkeypox virus concerning the 2022 outbreak

Does fenofibrate improve clinical outcomes in patients with COVID-19?

The effect of vaccination-induced immunity on viral loads of SARS-CoV-2 Omicron variant

Highly processed and refined foods contribute to rising obesity rates in the Western world

Outcomes from an Australian COVID-19 virtual ward during Omicron wave

New insight into how childhood traumas affect health outcomes

Terasaki Innovation Summit to focus on improving technological, entrepreneurial translation of personalized medicines

MGI Partners with ALACRiS Theranostics to Open New Customer Experience Center in Germany

Low-protein highly processed foods lead to higher energy intake

Study identifies a potential pharmacological target for treating COVID-19-associated heart failure

Study: Fenofibrate not a useful strategy for decreasing COVID-19 severity

Study uncovers a previously unknown propofol effect in neurons

Study helps to justify the use of Ayres Sensory Integration as a tool for autistic children

New analysis finds significant disparities in the treatment of familial hypercholesterolemia

EKF to showcase POCT connectivity solutions at MEDICA 2022

Lab Diagnostics and Automation - Third Edition eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo